Skip to content
Home/Companies/Pharma/Pentapharm

Pentapharm

Pharma·Switzerland·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Pentapharm?

Pentapharm is a Swiss Pharma company, currently owned by Orlando Management since 2025.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
Orlando Management
Investor
Orlando Management
Orlando Capital V · 2024 · Turnaround

Key facts

HQSwitzerland
SectorPharma
StatusActive

More from Orlando Capital V

Other portfolio companies in the same fund.

Kwantum
Active
ConsumerNetherlands· 2026
Leen Bakker
Active
ConsumerNetherlands· 2026
Buerstadt Furniture
Buerstadt Furniture
Active
ConsumerGermany· 2025
LEICHT Kuechen
LEICHT Kuechen
Active
ConsumerGermany· 2025
Stockerpoint
Stockerpoint
Active
ConsumerGermany· 2025
Illig
Active
IndustrialsGermany· 2024

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Pentapharm?

Pentapharm is currently owned by Orlando Management, through Orlando Capital V, since 2025.

When did Orlando Management acquire Pentapharm?

Orlando Management acquired Pentapharm in 2025.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue